Answers are grounded in this paper and cite their sources.
Objective To investigate clinical characteristics, co-detection patterns, and prognostic risk factors of human metapneumovirus (hMPV) infection in children. Methods Retrospective study of 621 children with laboratory-detected hMPV infection. Clinical data, laboratory indicators, and co-detection status were analyzed. Multivariate logistic regression identified independent risk factors for severe pneumonia. Results Median age was 3.50 years (IQR 1.75–4.75). Of 621 patients, 399 (64.3%) had Single-detection and 222 (35.7%) co-detection, with viral-viral co-detection dominant (68.9%) and rhinovirus the most common co-pathogen (39.6%). Only platelet count and aspartate aminotransferase differed significantly between groups (both P<0.01), with all inflammatory markers improving post-treatment (all P<0.001). Viral-bacterial co-detection was associated with longer hospitalization (median 6.5 days) and higher severe pneumonia rate (14.5%, both P<0.01). Multivariate analysis identified Streptococcus pneumoniae co-detection (aOR=8.43, 95%CI:1.50–47.32), prolonged fever duration (aOR=1.19, 95%CI:1.02–1.38), and procalcitonin ≥0.5 ng/mL (aOR=4.27, 95%CI:1.76–10.33) as independent risk factors for severe pneumonia. Older age (3–5 years: aOR=0.20; >5 years: aOR=0.03) showed significant protective effects. Conclusion hMPV infection is most prevalent in preschool children. Viral-bacterial co-detection was associated with worse clinical outcomes. S. pneumoniae co-detection, prolonged fever, and elevated procalcitonin were independently associated with increased risk, while older age was associated with reduced risk. These findings support early risk stratification and targeted intervention.
No takes yet. Share an insight, caveat, or question.
Wen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: